Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Product-specific COVID-19 vaccine effectiveness against secondary infection in close contacts, Navarre, Spain, April to August 2021
Iván Martínez‐Baz, Camino Trobajo‐Sanmartín, Ana Miqueleiz, et al.
Eurosurveillance (2021) Vol. 26, Iss. 39
Open Access | Times Cited: 69

Showing 26-50 of 69 citing articles:

SARS-CoV-2 Secondary Attack Rates in Vaccinated and Unvaccinated Household Contacts during Replacement of Delta with Omicron Variant, Spain
Israel López-Muñoz, Ariadna Torrella, Olga Pérez‐Quílez, et al.
Emerging infectious diseases (2022) Vol. 28, Iss. 10, pp. 1999-2008
Open Access | Times Cited: 16
The role of mild and asymptomatic infections on COVID-19 vaccines performance: A modeling study
Maíra Aguiar, Joseba Bidaurrazaga Van-Dierdonck, Javier Mar, et al.
Journal of Advanced Research (2021) Vol. 39, pp. 157-166
Open Access | Times Cited: 22
Household secondary attack rates of SARS-CoV-2 by variant and vaccination status: an updated systematic review and meta-analysis
Zachary J. Madewell, Yang Yang, Ira M. Longini, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 14
Comparison of the Risk of Hospitalization and Severe Disease Among Co-circulating Severe Acute Respiratory Syndrome Coronavirus 2 Variants
Camino Trobajo‐Sanmartín, Ana Miqueleiz, Marcela Guevara, et al.
The Journal of Infectious Diseases (2022) Vol. 227, Iss. 3, pp. 332-338
Open Access | Times Cited: 14
Durability of Protection Post–Primary COVID-19 Vaccination in the United States
Amanda B. Zheutlin, Miles Q. Ott, Ran Sun, et al.
Vaccines (2022) Vol. 10, Iss. 9, pp. 1458-1458
Open Access | Times Cited: 13
Duration of SARS-CoV-2 Immune Responses Up to Six Months Following Homologous or Heterologous Primary Immunization with ChAdOx1 nCoV-19 and BNT162b2 mRNA Vaccines
Ulrika Marking, Sebastian Havervall, Nina Greilert‐Norin, et al.
Vaccines (2022) Vol. 10, Iss. 3, pp. 359-359
Open Access | Times Cited: 12
COVID-19 vaccine effectiveness against SARS-CoV-2 infection during the Delta period, a nationwide study adjusting for chance of exposure, the Netherlands, July to December 2021
Catharina E van Ewijk, Marjolein N. Kooijman, Ewout Fanoy, et al.
Eurosurveillance (2022) Vol. 27, Iss. 45
Open Access | Times Cited: 11
Immunogenicity after a Third COVID-19 mRNA Booster in Solid Cancer Patients Who Previously Received the Primary Heterologous CoronaVac/ChAdOx1 Vaccine
Sutima Luangdilok, Passakorn Wanchaijiraboon, Nussara Pakvisal, et al.
Vaccines (2022) Vol. 10, Iss. 10, pp. 1613-1613
Open Access | Times Cited: 10
COVID‐19 vaccine effectiveness against hospitalization due to SARS‐CoV‐2: A test‐negative design study based on Severe Acute Respiratory Infection (SARI) sentinel surveillance in Spain
Clara Mazagatos, Concepción Delgado‐Sanz, Susana Monge, et al.
Influenza and Other Respiratory Viruses (2022) Vol. 16, Iss. 6, pp. 1014-1025
Open Access | Times Cited: 8
Non-Viral Delivery of Gene Therapy to the Tendon
Jing Jin, Qian Yang, You Zhou
Polymers (2022) Vol. 14, Iss. 16, pp. 3338-3338
Open Access | Times Cited: 8
Infection rate and factors affecting close contacts of COVID‐19 cases: A systematic review
Yunxuan Li, Jing Tan, Suoyi Tan, et al.
Journal of Evidence-Based Medicine (2022) Vol. 15, Iss. 4, pp. 385-397
Open Access | Times Cited: 8
Effectiveness of 4th doses of bivalent mRNA vaccine in reinfections from October 2022 to October 2023 in a general medicine office in Toledo (Spain)
José Luis Turabián
Archives of Community Medicine and Public Health (2024) Vol. 10, Iss. 1, pp. 001-006
Open Access | Times Cited: 1
A review of SARS-CoV-2 virology, vaccines, variants and their impact on the COVID-19 pandemic
Tetsuyuki Hirahata, Reeshan ul Quraish, Afraz ul Quraish, et al.
Reviews in Medical Microbiology (2024)
Closed Access | Times Cited: 1
COVID-19 infections, hospitalizations, and mortality in Navarre (Spain) between February 2020 and September 2022
Itziar Casado, Manuel García Cenoz, Nerea Egüés, et al.
Anales del Sistema Sanitario de Navarra (2023) Vol. 46, Iss. 2
Open Access | Times Cited: 3
SARS-CoV-2 Vaccine Effectiveness in Hospitalized Patients: A Multicenter Test-Negative Case–Control Study
Ireri Thirión-Romero, Rosario Fernández-Plata, Midori Pérez-Kawabe, et al.
Vaccines (2023) Vol. 11, Iss. 12, pp. 1779-1779
Open Access | Times Cited: 3
The effectiveness of BNT162b2 mRNA vaccine against COVID-19 caused by Delta variant of SARS-CoV-2: a systematic review and meta-analysis
Chia Siang Kow, Dinesh Sangarran Ramachandram, Syed Shahzad Hasan
Inflammopharmacology (2022) Vol. 30, Iss. 1, pp. 149-157
Open Access | Times Cited: 5
Hacia el control de la COVID-19 a través de la vacunación: obstáculos, desafíos y oportunidades. Informe SESPAS 2022
Pere Godoy, Jesús Castilla, Jenaro Astray, et al.
Gaceta Sanitaria (2022) Vol. 36, pp. S82-S86
Open Access | Times Cited: 5
Living with pulmonary sequelae of COVID‐19 and the implications for clinical nursing practice: A qualitative systematised review
Cameron Albright, Jacqueline Limoges, Gwen R. Rempel
Journal of Clinical Nursing (2023) Vol. 32, Iss. 21-22, pp. 7650-7660
Open Access | Times Cited: 2
Comparative Effectiveness of mRNA-1273 and BNT162b2 COVID-19 Vaccines Among Older Adults: Systematic Literature Review and Meta-Analysis Using the GRADE Framework
S Kavikondala, Katrin Haeussler, Xuan Wang, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 2
Assessment of Attitudes, Main Concerns and Sources of Knowledge Regarding COVID-19 Vaccination in Poland in the Unvaccinated Individuals—A Nationwide Survey
Mateusz Babicki, Wojciech Malchrzak, Agnieszka Mastalerz–Migas
Vaccines (2022) Vol. 10, Iss. 3, pp. 381-381
Open Access | Times Cited: 4
The Outcome of BNT162b2, ChAdOx1-Sand mRNA-1273 Vaccines and Two Boosters: A Prospective Longitudinal Real-World Study
Sanaa M. Kamal, Moheyeldeen Mohamed Naghib, Moataz Daadour, et al.
Viruses (2023) Vol. 15, Iss. 2, pp. 326-326
Open Access | Times Cited: 2
Risk Factors for Not Completing a 2-Dose Primary Series of Messenger RNA COVID-19 Vaccination in a Large Health Care System in Southern California: Retrospective Cohort Study
Stanley Xu, Vennis Hong, Lina S. Sy, et al.
JMIR Public Health and Surveillance (2023) Vol. 9, pp. e46318-e46318
Open Access | Times Cited: 2
Effectiveness of COVID-19 Vaccines and Post-vaccination SARS-COV 2 Infection, Hospitalization, and Mortality: a Systematic Review and Meta-analysis of Observational Studies
Kazem Rahmani, Rasoul Shavaleh, Mahtab Forouhi, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 5
Methodology of comparative studies on the relative effectiveness of COVID-19 vaccines: a systematic review
Erdenetuya Bolormaa, Ji Ae Shim, Young-Sook Choi, et al.
Osong Public Health and Research Perspectives (2024) Vol. 15, Iss. 5, pp. 395-408
Open Access
Age and product dependent vaccine effectiveness against SARS-CoV-2 infection and hospitalisation among adults in Norway: a national cohort study, July – November 2021
Jostein Starrfelt, Anders Skyrud Danielsen, Eirik Alnes Buanes, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 3

Scroll to top